12 October 2023
Ranok Therapeutics to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- CSO Kevin Foley to highlight application of company’s innovative CHAMPâ technology to target ERK5, an emerging cancer target
11 March 2024
Ranok Therapeutics Expands Clinical Testing of CHAMPâ BRD4 Protein Degrader RNK05047 to China
-- Study follows ongoing Phase 1 trial in U.S. and will enroll patients in China to evaluate the first protein degrader developed using Ranok’s innovative CHAMPâ technology
4 April 2024
Ranok Therapeutics to Present at American Association for Cancer Research (AACR) Annual Meeting 2024
--Poster presentations to highlight application of company's innovative CHAMP® technology to important cancer targets including KRAS
Ranok Therapeutics
United States
303 Wyman Street, Suite 300
Waltham, MA 02451
China
Floor 4, Building 16
Hexiang Science and Technology Center
Qiantang District, Hangzhou 310020
0571-86630936
© 2023 Ranok Therapeutics Co. Ltd.